Why the study?
Does enoxaparin reduce thromboembolic events and is it cost-effective compared to low-dose warfarin in patients undergoing total hip replacement surgery?
Population
Hypothetical cohort of 10,000 patients undergoing total hip replacement surgery
Comparison
Enoxaparin sodium prophylaxis vs Low-dose warfarin sodium prophylaxis or no…
Design
Other
Authors
Loading...
Supports modeled cost-effectiveness of enoxaparin post-hip replacement; leaves open randomized confirmation of outcomes.
Does enoxaparin reduce thromboembolic events and is it cost-effective compared to low-dose warfarin in patients undergoing total hip replacement surgery?
Enoxaparin provides more effective DVT prophylaxis than low-dose warfarin after total hip replacement at a reasonable incremental cost.
Joseph Menzin (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: